Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
123.07
-0.22 (-0.18%)
Nov 4, 2024, 4:00 PM EST - Market closed

Sarepta Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
11,7379,02111,3757,84113,4549,619
Upgrade
Market Cap Growth
40.00%-20.70%45.06%-41.72%39.87%25.01%
Upgrade
Enterprise Value
11,6638,67710,9077,42012,4229,064
Upgrade
Last Close Price
123.0796.43129.5890.05170.49129.04
Upgrade
PE Ratio
250.75-16.62-16.13-17.47-23.98-13.28
Upgrade
PS Ratio
7.797.2612.1911.1724.9125.26
Upgrade
PB Ratio
10.8910.5029.558.4517.6611.76
Upgrade
P/FCF Ratio
-29.47-15.63-31.94-16.28532.53-18.64
Upgrade
P/OCF Ratio
-37.67-18.01-34.96-17.69125.19-21.07
Upgrade
EV/Sales Ratio
7.756.9811.6910.5723.0023.80
Upgrade
EV/EBITDA Ratio
150.01-38.83-22.06-18.29-23.11-18.20
Upgrade
EV/EBIT Ratio
307.03-32.40-20.34-16.73-22.02-17.36
Upgrade
EV/FCF Ratio
-29.48-15.03-30.62-15.40491.69-17.56
Upgrade
Debt / Equity Ratio
1.291.634.201.231.410.89
Upgrade
Debt / FCF Ratio
-2.74-2.42-4.54-2.3642.47-1.41
Upgrade
Asset Turnover
0.460.390.300.230.220.22
Upgrade
Inventory Turnover
2.663.905.214.123.904.16
Upgrade
Quick Ratio
2.693.243.635.054.994.60
Upgrade
Current Ratio
3.903.954.135.755.975.55
Upgrade
Return on Equity (ROE)
5.20%-86.15%-107.16%-49.57%-70.15%-77.29%
Upgrade
Return on Assets (ROA)
0.72%-5.24%-10.68%-9.04%-14.67%-18.84%
Upgrade
Return on Capital (ROIC)
1.04%-7.86%-16.47%-14.21%-20.85%-21.75%
Upgrade
Earnings Yield
0.40%-5.94%-6.18%-5.34%-4.12%-7.43%
Upgrade
FCF Yield
-4.32%-6.40%-3.13%-6.14%0.19%-5.37%
Upgrade
Buyback Yield / Dilution
-10.93%-5.53%-7.75%-4.24%-5.90%-11.12%
Upgrade
Total Shareholder Return
-10.93%-5.53%-7.75%-4.24%-5.90%-11.12%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.